What they were paid
BIO-TECHNE Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $100,000 | $99,957 | $99,984 | $481 | $300,422 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIO-TECHNE Corp DEF 14A filed September 19, 2025, accession 0001308179-25-000599, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025BIO-TECHNE pays directors a $75,000 cash retainer and $200,000 in 50% stock options, 50% restricted stock.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Nominating/Governance
The rest of the BIO-TECHNE board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alpna Seth, Ph.D | Independent Director | $285,422 |
| Amy Herr, Ph.D | Independent Director | $181,360 |
| Joseph Keegan, Ph.D | Independent Director | $275,422 |
| Judith Klimovsky, M.D | Independent Director | $275,346 |
| Julie L. Bushman | Independent Director | $292,922 |
| Kim Kelderman | Director | $0 |
| Robert V. Baumgartner | Chair of the Board | $400,422 |
| Roeland Nusse, Ph.D | Independent Director | $290,422 |
| Rupert Vessey, MA, BM BCh, FRCP, DPhil | Independent Director | $275,422 |
The full BIO-TECHNE compensation record
free company briefThis page is one director within BIO-TECHNE's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat